TI
CBAY

Trexquant Investment’s Cymabay Therapeutics CBAY Stock Holding History

Trexquant Investment’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-219,755
Closed -$3.28M – 1887
2023
Q3 		$3.28M Buy
219,755
+163,278
+289% +$2.16M 0.08% 338
2023
Q2 		$618K Sell
56,477
-7,409
-12% -$69K 0.02% 927
2023
Q1 		$557K Buy
+63,886
New +$511K 0.02% 952
2021
Q1 		– Sell
-52,695
Closed -$302K – 1551
2020
Q4 		$302K Buy
+52,695
New +$399K 0.03% 687
2019
Q2 		– Sell
-11,794
Closed -$157K – 1200
2019
Q1 		$157K Buy
+11,794
New +$125K 0.01% 899
2018
Q1 		– Sell
-22,511
Closed -$207K – 1456
2017
Q4 		$207K Buy
+22,511
New +$192K 0.02% 926

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return